PARIS — The survival benefits of primary-prevention device therapy seen in seminal trials reported in the early 2000s still apply today, suggests a registry study from Sweden that also saw gross ...
CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the ...
PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...
First-in-human report for UltiSynq CSP ICD lead ...
From heart failure with multiple comorbidities to rare disease scenarios, ICD-10 coding for complex conditions demands precision, updated knowledge, and strong provider collaboration. The FY 2026 ...